RIGEL PHARMACEUTICALS INC - COM NEW (RIGL)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM NEW
Shares, excl. options Q1 2024: 96.2 M
Holdings value Q1 2024: $142 M
Value change Q1 2024: +$6.48 M
Grand Portfolio weight change Q1 2024: +0%
Number of holders: 108
Number of buys Q1 2024: 45
Number of sells Q1 2024: -46
Average buys Q1 2024 %: +0%
Average sells Q1 2024 %: 0%
CUSIP: 766559603

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	96.2 M	$142 M	+$6.48 M	50.2 K	728 K	$1.48	108
2023 Q4	91.9 M	$133 M	-$10.3 M	56.4 K	930 K	$1.45	108
2023 Q3	106 M	$115 M	-$5.31 M	64.8 K	592 K	$1.08	102
2023 Q2	111 M	$143 M	-$2.53 M	99.1 K	734 K	$1.29	112
2023 Q1	113 M	$149 M	+$4.9 M	58.3 K	525 K	$1.32	120
2022 Q4	109 M	$163 M	-$25.5 M	16.8 K	641 K	$1.50	112
2022 Q3	108 M	$127 M	-$11.8 M	40 K	385 K	$1.18	122
2022 Q2	120 M	$136 M	-$33.1 M	441 K	889 K	$1.13	119
2022 Q1	133 M	$399 M	-$6.5 M	420 K	879 K	$2.99	152
2021 Q4	120 M	$318 M	-$4.67 M	764 K	632 K	$2.65	148
2021 Q3	137 M	$498 M	-$11.2 M	1.86 M	2.25 M	$3.63	154
2021 Q2	141 M	$613 M	-$9.24 M	2.5 M	2.83 M	$4.34	152
2021 Q1	144 M	$492 M	+$14.7 M	1.41 M	1.44 M	$3.42	142
2020 Q4	134 M	$469 M	-$4.18 M	1.39 M	1.68 M	$3.50	135
2020 Q3	139 M	$334 M	-$7.71 M	1.52 M	773 K	$2.40	130
2020 Q2	144 M	$263 M	-$8.09 M	49 K	7 K	$1.83	127
2020 Q1	146 M	$228 M	+$1.65 M	51 K	40 K	$1.56	114
2019 Q4	148 M	$316 M	+$462 K	61 K	4 K	$2.14	127
2019 Q3	147 M	$276 M	-$21.6 M	42 K	69 K	$1.87	122
2019 Q2	153 M	$406 M	+$21.2 M	350 K	735 K	$2.61	122
2019 Q1	153 M	$394 M	-$5.03 M	113 K	520 K	$2.57	121
2018 Q4	159 M	$365 M	+$1.16 M	551 K	1.17 M	$2.30	126
2018 Q3	157 M	$502 M	+$243 K	902 K	283 K	$3.21	131
2018 Q2	158 M	$447 M	+$53.3 M	612 K	364 K	$2.83	127
2018 Q1	139 M	$490 M	+$7.66 M	5.05 M	6.4 M	$3.54	114
2017 Q4	136 M	$528 M	+$105 M	327 K	539 K	$3.88	117
2017 Q3	109 M	$278 M	-$877 K	105 K	330 K	$2.54	104
2017 Q2	109 M	$299 M	-$2.18 M	104 K	280 K	$2.73	105
2017 Q1	108 M	$357 M	+$88.6 M	89 K	89 K	$3.31	97
2016 Q4	88.3 M	$210 M	-$2.68 M	249 K	30 K	$2.38	100
2016 Q3	86.4 M	$317 M	+$18 M	774 K	2.5 M	$3.67	116
2016 Q2	83.7 M	$187 M	+$5.01 M	104 K	30 K	$2.23	114
2016 Q1	80.3 M	$167 M	-$6.06 M		0	$2.08	113
2015 Q4	81.8 M	$248 M	+$5.76 M		57 K	$3.03	119
2015 Q3	79.7 M	$197 M	+$2.11 M	0	47 K	$2.47	116
2015 Q2	78 M	$250 M	+$7.29 M	204 K	66 K	$3.21	117
2015 Q1	75.8 M	$271 M	+$4.19 M	161 K	53 K	$3.57	108
2014 Q4	76 M	$172 M	-$6.07 M		3 K	$2.27	88
2014 Q3	78.7 M	$153 M	+$1.25 M			$1.94	97
2014 Q2	75.7 M	$275 M	-$1.22 M	13 K	41 K	$3.63	96
2014 Q1	77.4 M	$300 M	-$4.88 M	1.08 M	429 K	$3.88	108